In addition, patients with high-positive ACPA titers (>15 U/mL) showed higher risk of prevalent ILD (OR, 1.91; 95% confidence interval [CI], 1.04–3.49) than that in ACPA-negative patients [88]. This evidence concerns the gene PRTN3 and interstitial lung disease.